Immunization Safety Review
Influenza Vaccine and Possible Neurological Complications
13 March, 2003
Hotel Monaco
Athens Room, 700 F St., NW
Washington, DC

Agenda

PLEASE NOTE:
Online presentations from the Influenza Vaccine and Possible Neurological Complications meeting are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasting any portion of the speaker's presentations. Additional copyright and legal policies of The National Academies can be read here.


Internet Explorer is recommended for viewing the slides. Some presentations may not be accessible with Netscape Navigator. The presentations are available as PDF files which require Adobe Acrobat Reader. Click here to download Adobe Acrobat Reader for free.

Welcome and Opening Remarks
Marie McCormick, MD, ScD, Committee Chair
Audio

Influenza
Robert G. Webster, PhD, St. Jude Children's Research Hospital
Slides
Audio

Guillain-Barré Syndrome
John Griffin, MD,The Johns Hopkins University School of Medicine
No slides available at this time
Audio

The Yearly Production of Influenza Vaccine
Roland Levandowski, MD, Food and Drug Administration
Slides
Audio

VAERS Reports Related to Influenza Vaccine
Penina Haber,MPH, Centers for Disease Control and Prevention
Slides
Audio

Discussion
Audio

Studies of Guillain-Barré Syndrome After Influenza Vaccination
Robert Chen, MD, Centers for Disease Control and Prevention
Slides
Audio

Guillain-Barré Syndrome and the 1992-1993 and 1993-1994 Influenza Vaccines
Tamar Lasky, PhD, National Institute of Child Health & Human Development
Slides
Audio

Safety of Influenza Vaccine in the Pediatric Population
Eric K. France, MD, MSPH, Preventive Medicine Kaiser Permanente Colorado
Slides
Handout
Audio

Intranasal Vaccines
Kathryn Edwards, MD, Vanderbilt University School of Medicine
(presenting via conference call)
Slides
Audio

VSD Data Related to Influenza Vaccine and Incidence/Relapse of MS
Frank DeStefano, MD, Centers for Disease Control and Prevention
Slides
Audio

Use of Medicare Data to Evaluate Adverse Events After Influenza Vaccine
Dale Burwen, MD, Food and Drug Administration
Slides
Audio